165 related articles for article (PubMed ID: 2031692)
1. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers.
Lallemant-Le Coeur S; Lallemant M; Cheynier D; Nzingoula S; Drucker J; Larouze B
AIDS; 1991 Feb; 5(2):195-9. PubMed ID: 2031692
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.
Thaithumyanon P; Thisyakorn U; Punnahitananda S; Praisuwanna P; Ruxrungtham K
Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):482-6. PubMed ID: 11289006
[TBL] [Abstract][Full Text] [Related]
3. Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature.
O'Brien KL; Ruff AJ; Louis MA; Desormeaux J; Joseph DJ; McBrien M; Coberly J; Boulos R; Halsey NA
Pediatrics; 1995 Mar; 95(3):414-8. PubMed ID: 7862483
[TBL] [Abstract][Full Text] [Related]
4. [HIV-infection, AIDS and BCG vaccination].
Toida I
Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
[TBL] [Abstract][Full Text] [Related]
5. Tuberculin conversion and leukocyte migration inhibition test after BCG vaccination in newborn infants.
Faridi M; Kaur S; Krishnamurthy S; Kumari P
Hum Vaccin; 2009 Oct; 5(10):690-5. PubMed ID: 19855160
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.
Saroha M; Faridi MM; Batra P; Kaur I; Dewan DK
Hum Vaccin Immunother; 2015; 11(12):2864-71. PubMed ID: 26431252
[TBL] [Abstract][Full Text] [Related]
7. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.
Taha TE; Dallabetta GA; Canner JK; Chiphangwi JD; Liomba G; Hoover DR; Miotti PG
Int J Epidemiol; 1995 Oct; 24(5):1022-9. PubMed ID: 8557435
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1.
Ryder RW; Oxtoby MJ; Mvula M; Batter V; Baende E; Nsa W; Davachi F; Hassig S; Onorato I; Deforest A
J Pediatr; 1993 May; 122(5 Pt 1):697-702. PubMed ID: 8496745
[TBL] [Abstract][Full Text] [Related]
10. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
11. Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine.
Alrabiaah AA; Alsubaie SS; Bukhari EI; Gad A; Alzamel FA
Ann Saudi Med; 2012; 32(1):4-8. PubMed ID: 22156633
[TBL] [Abstract][Full Text] [Related]
12. Surgical complications of bacille Calmette-Guérin (BCG) infection in HIV-infected children: time for a change in policy.
Karpelowsky JS; Alexander AG; Peek SD; Millar AJ; Rode H
S Afr Med J; 2008 Oct; 98(10):801-4. PubMed ID: 19115758
[TBL] [Abstract][Full Text] [Related]
13. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
Menzies D
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
[TBL] [Abstract][Full Text] [Related]
14. BCG immunization and paediatric HIV infection.
Wkly Epidemiol Rec; 1992 May; 67(18):129-32. PubMed ID: 1581177
[No Abstract] [Full Text] [Related]
15. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
16. The influence of BCG immunization on tuberculin reactivity in healthy Chilean women in the third trimester of pregnancy.
Sepulveda RL; Gonzalez B; Gerszencveig R; Ferrer X; Martinez B; Sorensen RU
Tuber Lung Dis; 1995 Feb; 76(1):28-34. PubMed ID: 7718843
[TBL] [Abstract][Full Text] [Related]
17. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
[TBL] [Abstract][Full Text] [Related]
18. Incidence of lymphadenitis following Bacillus Calmette-Guérin (BCG) vaccination in north Indian children.
Rangesh S; Vaidya PC; Mehra N; Gupta S; Bharti B
Indian J Tuberc; 2022 Oct; 69(4):596-601. PubMed ID: 36460395
[TBL] [Abstract][Full Text] [Related]
19. Bacillus Calmette-Guerin vaccination in preterm infants.
Okan F; Karagoz S; Nuhoglu A
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1337-41. PubMed ID: 17167949
[TBL] [Abstract][Full Text] [Related]
20. Novel vaccine prime and selective BCG boost: a new tuberculosis vaccine strategy for infants of HIV-infected mothers.
Hatherill M; Mahomed H; Hanekom W
Vaccine; 2010 Jun; 28(29):4550-2. PubMed ID: 20470797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
